- •Contents
- •General Introduction
- •Objectives
- •1 Introduction to Glaucoma: Terminology, Epidemiology, and Heredity
- •Definitions
- •Classification
- •Open-Angle, Angle-Closure, Primary, and Secondary Glaucomas
- •Combined-Mechanism Glaucoma
- •Epidemiologic Aspects of Glaucoma
- •Primary Open-Angle Glaucoma
- •Primary Angle-Closure Glaucoma
- •Genetics, Environmental Factors, and Glaucoma
- •Environmental Factors
- •Genetic Testing
- •Aqueous Humor Formation
- •Suppression of Aqueous Formation
- •Rate of Aqueous Formation
- •Aqueous Humor Outflow
- •Trabecular Outflow
- •Uveoscleral Outflow
- •Tonography
- •Episcleral Venous Pressure
- •Intraocular Pressure
- •Distribution in the Population and Relation to Glaucoma
- •Factors Influencing Intraocular Pressure
- •Diurnal Variation
- •Clinical Measurement of Intraocular Pressure
- •Infection Control in Clinical Tonometry
- •3 Clinical Evaluation
- •History and General Examination
- •Refraction
- •External Adnexae
- •Pupils
- •Biomicroscopy
- •Gonioscopy
- •Direct and Indirect Gonioscopy
- •Gonioscopic Assessment and Documentation
- •The Optic Nerve
- •Anatomy and Pathology
- •Glaucomatous Optic Neuropathy
- •Examination of the Optic Nerve Head
- •The Visual Field
- •Clinical Perimetry
- •Variables in Perimetry
- •Automated Static Perimetry
- •Interpretation of a Single Visual Field
- •Interpretation of a Series of Visual Fields
- •Patterns of Glaucomatous Nerve Loss
- •Manual Perimetry
- •Other Tests
- •4 Open-Angle Glaucoma
- •Primary Open-Angle Glaucoma
- •Clinical Features
- •Risk Factors for POAG Other Than IOP
- •Associated Disorders
- •Prognosis
- •Clinical Features
- •Differential Diagnosis
- •Diagnostic Evaluation
- •Prognosis and Therapy
- •The Glaucoma Suspect
- •Ocular Hypertension
- •Secondary Open-Angle Glaucoma
- •Exfoliation Syndrome
- •Pigmentary Glaucoma
- •Lens-Induced Glaucoma
- •Intraocular Tumors
- •Ocular Inflammation and Secondary Glaucoma
- •Elevated Episcleral Venous Pressure
- •Accidental and Surgical Trauma
- •Schwartz Syndrome (Schwartz-Matsuo Syndrome)
- •Drugs and Glaucoma
- •5 Angle-Closure Glaucoma
- •Introduction
- •Pathogenesis and Pathophysiology of Angle Closure
- •Pupillary Block
- •Angle Closure Without Pupillary Block
- •Lens-Induced Angle-Closure Glaucoma
- •Iris-Induced Angle Closure
- •Primary Angle Closure
- •Risk Factors for Developing Primary Angle Closure
- •Acute Primary Angle Closure
- •Subacute or Intermittent Angle Closure
- •Chronic Angle Closure
- •The Occludable, or Narrow, Anterior Chamber Angle
- •Plateau Iris
- •Secondary Angle Closure With Pupillary Block
- •Lens-Induced Angle Closure
- •Secondary Angle Closure Without Pupillary Block
- •Neovascular Glaucoma
- •Iridocorneal Endothelial Syndrome
- •Tumors
- •Inflammation
- •Aqueous Misdirection
- •Nonrhegmatogenous Retinal Detachment and Uveal Effusions
- •Epithelial and Fibrous Ingrowth
- •Trauma
- •Retinal Surgery and Retinal Vascular Disease
- •Nanophthalmos
- •Persistent Fetal Vasculature
- •Flat Anterior Chamber
- •Drug-Induced Secondary Angle-Closure Glaucoma
- •6 Childhood Glaucoma
- •Classification
- •Genetics
- •Primary Congenital Glaucoma
- •Juvenile Open-Angle Glaucoma
- •Developmental Glaucomas of Childhood With Associated Ocular or Systemic Anomalies
- •Axenfeld-Rieger Syndrome
- •Peters Anomaly
- •Aniridia
- •Sturge-Weber Syndrome
- •Neurofibromatosis
- •Secondary Glaucomas
- •Aphakic Glaucoma
- •Evaluating the Pediatric Glaucoma Patient
- •History
- •Visual Acuity
- •External Examination
- •Anterior Segment Examination
- •Tonometry
- •Central Corneal Thickness
- •Gonioscopy
- •Optic Nerve and Fundus Evaluation
- •Axial Length
- •Other Testing
- •Treatment Overview
- •Surgical Management
- •Medical Management
- •Prognosis and Follow-Up
- •7 Medical Management of Glaucoma
- •Medical Agents
- •Prostaglandin Analogues
- •β-Adrenergic Antagonists
- •Adrenergic Agonists
- •Carbonic Anhydrase Inhibitors
- •Parasympathomimetic Agents
- •Combined Medications
- •Hyperosmotic Agents
- •General Approach to Medical Treatment
- •Open-Angle Glaucoma
- •Angle-Closure Glaucoma
- •Administration of Ocular Medications
- •Use of Glaucoma Medications During Pregnancy or by Nursing Mothers
- •Use of Glaucoma Medications in Elderly Patients
- •Generic Medications
- •Compliance
- •8 Surgical Therapy for Glaucoma
- •Surgery for Open-Angle Glaucoma
- •Laser Trabeculoplasty
- •Incisional Surgery for Open-Angle Glaucomas
- •Combined Cataract and Filtering Surgery
- •Surgery for Angle-Closure Glaucoma
- •Laser Iridotomy
- •Laser Gonioplasty, or Peripheral Iridoplasty
- •Incisional Surgery for Angle Closure
- •Other Procedures to Lower IOP
- •Glaucoma Drainage Device Implantation
- •Ciliary Body Ablation Procedures
- •Nonpenetrating Glaucoma Surgery
- •Special Considerations in the Surgical Management of Elderly Patients
- •Basic Texts
- •Related Academy Materials
- •Requesting Continuing Medical Education Credit
the iris and vitreous face from moving forward. Laser iridotomies, often multiple, are required to relieve the block.
Pupillary block may also occur following posterior capsulotomy when vitreous obstructs the pupil. A condition referred to as capsular block may also be seen, whereby retained viscoelastic or fluid in the capsular bag pushes a posterior chamber IOL anteriorly, which may narrow the angle.
Secondary Angle Closure Without Pupillary Block
A number of disorders can lead to secondary angle closure without pupillary block, and several are discussed in this section. This form of secondary angle closure may occur through 1 of 2 mechanisms:
contraction of an inflammatory, hemorrhagic, or vascular membrane, band, or exudate in the angle, leading to PAS
forward displacement of the lens–iris interface, often accompanied by swelling and anterior rotation of the ciliary body
Neovascular Glaucoma
This common, severe type of secondary ACG is caused by a variety of disorders characterized by retinal or ocular ischemia or ocular inflammation (Table 5-3). The most common causes are diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome. The disease is characterized by fine arborizing blood vessels on the surface of the iris, pupil margin, and trabecular meshwork, which are accompanied by a fibrous membrane. The contraction of the fibrovascular membrane results in the formation of PAS, leading to the development of secondary ACG. In some cases, a fibrous membrane may be evident without active angle neovascularization. Moreover, angle vessels may be present without vessels on the iris surface.
Table 5-3
Neovascularization of the anterior segment usually presents in a classic pattern, which starts with fine vascular tufts at the pupillary margin (Fig 5-10). As these vessels grow, they extend radially over the iris. The neovascularization crosses the ciliary body and scleral spur as fine single vessels that then branch as they reach and involve the trabecular meshwork (see Chapter 3, Fig 3-6). Often the trabecular meshwork takes on a reddish coloration. With contraction of the fibrovascular membrane, PAS develop and coalesce, gradually closing the angle (Fig 5-11). Because the fibrovascular membrane typically does not grow over healthy corneal endothelium, the PAS end at the Schwalbe line, distinguishing this condition from other secondary ACGs that result from an abnormal corneal
endothelium, such as ICE syndrome, which is discussed in the following section (Figs 5-12, 5-13).
Figure 5-10 The initial presentation of iris neovascularization is usually small vascular tufts (arrows) at the pupillary margin.
(Courtesy of Steven T. Simmons, MD.)
Figure 5-11 Iris neovascularization. With progressive angle involvement, PAS develop with contraction of the fibrovascular membrane, resulting in secondary neovascular glaucoma.
Figure 5-12 With end-stage neovascular glaucoma, total angle closure occurs, obscuring the iris neovascularization. The PAS end at the Schwalbe line because the fibrovascular membrane does not grow over healthy corneal endothelium.
(Courtesy of Steven T. Simmons, MD.)
Figure 5-13 With growth, iris neovascularization extends from the pupillary margin radially toward the anterior chamber
angle. (Courtesy of Steven T. Simmons, MD.)
Clinically, patients often present with an acute or subacute glaucoma associated with reduced vision, pain, conjunctival hyperemia, microcystic corneal edema, and high IOP. While performing gonioscopy in patients suspected of having neovascularization, the clinician may find it helpful to use a bright slit-lamp beam of light and high magnification in order to best visualize these fine vessels.
In rare instances, anterior segment neovascularization may occur without demonstrable retinal ischemia, as in Fuchs heterochromic iridocyclitis and other types of uveitis, exfoliation syndrome, or isolated iris melanomas. When an ocular cause cannot be found, carotid artery occlusive disease should be considered. In establishing a correct diagnosis, the clinician should distinguish dilated iris vessels associated with inflammation from newly formed abnormal blood vessels.
Because the prognosis for neovascular glaucoma is poor, prevention and early diagnosis are desirable. Gonioscopy is vitally important to the early diagnosis because angle neovascularization can occur without iris neovascularization. In central retinal vein occlusion (CRVO), approximately 10% of patients develop angle neovascularization alone. The most common cause of iris neovascularization is ischemic retinopathy, and panretinal photocoagulation should be performed whenever possible. The treatment of choice when the ocular media are clear is panretinal photocoagulation. When cloudy media prevent laser therapy, panretinal cryotherapy should be considered as an alternative to vitrectomy to clear the media with endophotocoagulation or subsequent panretinal photocoagulation. Frequently, marked involution of the neovascularization occurs. The resulting decrease in neovascularization after panretinal photocoagulation may reduce or normalize the IOP, depending on the degree of synechial closure that has occurred. Even in the
